nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolazoline—Amphetamine—CARTPT—acquired immunodeficiency syndrome	0.0693	0.522	CrCbGaD
Tolazoline—L-Phenylalanine—TAT—acquired immunodeficiency syndrome	0.0634	0.478	CrCbGaD
Tolazoline—HRH2—skin of body—acquired immunodeficiency syndrome	0.0317	0.0735	CbGeAlD
Tolazoline—HRH2—digestive system—acquired immunodeficiency syndrome	0.0253	0.0588	CbGeAlD
Tolazoline—ADRA2A—blood plasma—acquired immunodeficiency syndrome	0.0246	0.057	CbGeAlD
Tolazoline—HRH2—blood—acquired immunodeficiency syndrome	0.0241	0.056	CbGeAlD
Tolazoline—HRH2—lung—acquired immunodeficiency syndrome	0.0212	0.0491	CbGeAlD
Tolazoline—HRH2—nervous system—acquired immunodeficiency syndrome	0.0196	0.0455	CbGeAlD
Tolazoline—HRH2—central nervous system—acquired immunodeficiency syndrome	0.0189	0.0438	CbGeAlD
Tolazoline—HRH2—brain—acquired immunodeficiency syndrome	0.015	0.0348	CbGeAlD
Tolazoline—HRH2—lymph node—acquired immunodeficiency syndrome	0.0145	0.0336	CbGeAlD
Tolazoline—ADRA1A—lymphoid tissue—acquired immunodeficiency syndrome	0.0126	0.0292	CbGeAlD
Tolazoline—ADRA1A—blood—acquired immunodeficiency syndrome	0.0118	0.0275	CbGeAlD
Tolazoline—ADRA2C—blood—acquired immunodeficiency syndrome	0.0113	0.0262	CbGeAlD
Tolazoline—ADRA2C—spinal cord—acquired immunodeficiency syndrome	0.0109	0.0252	CbGeAlD
Tolazoline—ADRA2C—vagina—acquired immunodeficiency syndrome	0.0105	0.0243	CbGeAlD
Tolazoline—ADRA2C—lung—acquired immunodeficiency syndrome	0.00988	0.023	CbGeAlD
Tolazoline—HRH1—digestive system—acquired immunodeficiency syndrome	0.00961	0.0223	CbGeAlD
Tolazoline—ADRA1A—nervous system—acquired immunodeficiency syndrome	0.00961	0.0223	CbGeAlD
Tolazoline—ADRA1A—central nervous system—acquired immunodeficiency syndrome	0.00925	0.0215	CbGeAlD
Tolazoline—ADRA2C—nervous system—acquired immunodeficiency syndrome	0.00915	0.0213	CbGeAlD
Tolazoline—ADRA2A—blood—acquired immunodeficiency syndrome	0.009	0.0209	CbGeAlD
Tolazoline—ADRA2C—central nervous system—acquired immunodeficiency syndrome	0.00881	0.0205	CbGeAlD
Tolazoline—ADRA2A—spinal cord—acquired immunodeficiency syndrome	0.00867	0.0201	CbGeAlD
Tolazoline—HRH1—vagina—acquired immunodeficiency syndrome	0.00849	0.0197	CbGeAlD
Tolazoline—ADRA2A—vagina—acquired immunodeficiency syndrome	0.00834	0.0194	CbGeAlD
Tolazoline—HRH1—lung—acquired immunodeficiency syndrome	0.00803	0.0186	CbGeAlD
Tolazoline—ADRA2A—lung—acquired immunodeficiency syndrome	0.00789	0.0183	CbGeAlD
Tolazoline—HRH1—nervous system—acquired immunodeficiency syndrome	0.00744	0.0173	CbGeAlD
Tolazoline—ADRA1A—brain—acquired immunodeficiency syndrome	0.00734	0.0171	CbGeAlD
Tolazoline—ADRA2A—nervous system—acquired immunodeficiency syndrome	0.0073	0.017	CbGeAlD
Tolazoline—HRH1—central nervous system—acquired immunodeficiency syndrome	0.00716	0.0166	CbGeAlD
Tolazoline—ADRA2A—central nervous system—acquired immunodeficiency syndrome	0.00703	0.0163	CbGeAlD
Tolazoline—ADRA2C—brain—acquired immunodeficiency syndrome	0.007	0.0163	CbGeAlD
Tolazoline—ADRA2C—lymph node—acquired immunodeficiency syndrome	0.00676	0.0157	CbGeAlD
Tolazoline—HRH1—brain—acquired immunodeficiency syndrome	0.00568	0.0132	CbGeAlD
Tolazoline—ADRA2A—brain—acquired immunodeficiency syndrome	0.00558	0.013	CbGeAlD
Tolazoline—HRH1—lymph node—acquired immunodeficiency syndrome	0.00549	0.0128	CbGeAlD
Tolazoline—ADRA2A—lymph node—acquired immunodeficiency syndrome	0.00539	0.0125	CbGeAlD
Tolazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00131	0.003	CbGpPWpGaD
Tolazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00131	0.003	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00131	0.00299	CbGpPWpGaD
Tolazoline—ADRA2A—Platelet activation, signaling and aggregation—CSF2—acquired immunodeficiency syndrome	0.0013	0.00297	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00129	0.00296	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00129	0.00296	CbGpPWpGaD
Tolazoline—ADRA2C—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.00129	0.00296	CbGpPWpGaD
Tolazoline—HRH1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00129	0.00295	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00129	0.00294	CbGpPWpGaD
Tolazoline—HRH2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00126	0.0029	CbGpPWpGaD
Tolazoline—HRH2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00126	0.0029	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00126	0.00289	CbGpPWpGaD
Tolazoline—ADRA2A—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.00125	0.00287	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00125	0.00287	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—TAT—acquired immunodeficiency syndrome	0.00125	0.00286	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00123	0.00281	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00123	0.00281	CbGpPWpGaD
Tolazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00123	0.00281	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.00122	0.0028	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.0012	0.00275	CbGpPWpGaD
Tolazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00118	0.00271	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00117	0.00269	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00117	0.00268	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00117	0.00267	CbGpPWpGaD
Tolazoline—HRH1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00116	0.00267	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00116	0.00266	CbGpPWpGaD
Tolazoline—HRH1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.00115	0.00263	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.00115	0.00263	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.00115	0.00263	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00114	0.00262	CbGpPWpGaD
Tolazoline—ADRA2A—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.00113	0.00259	CbGpPWpGaD
Tolazoline—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.00113	0.00258	CbGpPWpGaD
Tolazoline—ADRA2B—Hemostasis—IFNA1—acquired immunodeficiency syndrome	0.00113	0.00258	CbGpPWpGaD
Tolazoline—ADRA2B—Platelet activation, signaling and aggregation—ALB—acquired immunodeficiency syndrome	0.00112	0.00255	CbGpPWpGaD
Tolazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00111	0.00253	CbGpPWpGaD
Tolazoline—HRH1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.0011	0.00251	CbGpPWpGaD
Tolazoline—HRH1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.0011	0.00251	CbGpPWpGaD
Tolazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00109	0.00251	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00109	0.00249	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00107	0.00246	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00107	0.00246	CbGpPWpGaD
Tolazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00107	0.00246	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00107	0.00245	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00106	0.00243	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—AGPS—acquired immunodeficiency syndrome	0.00106	0.00243	CbGpPWpGaD
Tolazoline—ADRA2C—Hemostasis—IFNA1—acquired immunodeficiency syndrome	0.00105	0.00241	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00105	0.0024	CbGpPWpGaD
Tolazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.00105	0.0024	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00104	0.00239	CbGpPWpGaD
Tolazoline—ADRA2C—Platelet activation, signaling and aggregation—ALB—acquired immunodeficiency syndrome	0.00104	0.00238	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00102	0.00234	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—TAT—acquired immunodeficiency syndrome	0.00101	0.00232	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.001	0.00229	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000999	0.00229	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000999	0.00229	CbGpPWpGaD
Tolazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000998	0.00228	CbGpPWpGaD
Tolazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000986	0.00226	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000976	0.00223	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000968	0.00222	CbGpPWpGaD
Tolazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000967	0.00221	CbGpPWpGaD
Tolazoline—HRH2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000962	0.0022	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000951	0.00218	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00095	0.00217	CbGpPWpGaD
Tolazoline—HRH2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000948	0.00217	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000935	0.00214	CbGpPWpGaD
Tolazoline—ADRA2B—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	0.000904	0.00207	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000902	0.00207	CbGpPWpGaD
Tolazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000899	0.00206	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000882	0.00202	CbGpPWpGaD
Tolazoline—ADRA2B—Hemostasis—CSF2—acquired immunodeficiency syndrome	0.000882	0.00202	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000874	0.002	CbGpPWpGaD
Tolazoline—HRH2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000867	0.00198	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000862	0.00197	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000861	0.00197	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—IFNA1—acquired immunodeficiency syndrome	0.000855	0.00196	CbGpPWpGaD
Tolazoline—ADRA2A—Platelet activation, signaling and aggregation—ALB—acquired immunodeficiency syndrome	0.000846	0.00194	CbGpPWpGaD
Tolazoline—ADRA2C—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	0.000845	0.00193	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000843	0.00193	CbGpPWpGaD
Tolazoline—HRH1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000833	0.00191	CbGpPWpGaD
Tolazoline—ADRA2C—Hemostasis—CSF2—acquired immunodeficiency syndrome	0.000824	0.00189	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000818	0.00187	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000798	0.00183	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000794	0.00182	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000791	0.00181	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000787	0.0018	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00076	0.00174	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00076	0.00174	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00076	0.00174	CbGpPWpGaD
Tolazoline—HRH1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000751	0.00172	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000744	0.0017	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000744	0.0017	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000742	0.0017	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000739	0.00169	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000737	0.00169	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000722	0.00165	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000718	0.00164	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000709	0.00162	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000709	0.00162	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000695	0.00159	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000695	0.00159	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000687	0.00157	CbGpPWpGaD
Tolazoline—ADRA2A—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	0.000686	0.00157	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000684	0.00157	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000678	0.00155	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000678	0.00155	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000675	0.00155	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000675	0.00155	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000671	0.00154	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—CSF2—acquired immunodeficiency syndrome	0.000669	0.00153	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000661	0.00151	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000658	0.00151	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000649	0.00149	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000646	0.00148	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000642	0.00147	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000632	0.00145	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000632	0.00145	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000631	0.00144	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000631	0.00144	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00062	0.00142	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00062	0.00142	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000619	0.00142	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000619	0.00142	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000607	0.00139	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000607	0.00139	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000603	0.00138	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.0006	0.00137	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000598	0.00137	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000587	0.00134	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000576	0.00132	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000576	0.00132	CbGpPWpGaD
Tolazoline—ADRA2B—Hemostasis—ALB—acquired immunodeficiency syndrome	0.000575	0.00132	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000572	0.00131	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000566	0.0013	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000564	0.00129	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000564	0.00129	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000562	0.00129	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000562	0.00129	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000561	0.00128	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000557	0.00128	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000552	0.00126	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000552	0.00126	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000545	0.00125	CbGpPWpGaD
Tolazoline—ADRA2C—Hemostasis—ALB—acquired immunodeficiency syndrome	0.000537	0.00123	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000529	0.00121	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000521	0.00119	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000521	0.00119	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000516	0.00118	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000514	0.00118	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000512	0.00117	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000512	0.00117	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.00051	0.00117	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000508	0.00116	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000506	0.00116	CbGpPWpGaD
Tolazoline—HRH2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000501	0.00115	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.00048	0.0011	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000476	0.00109	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000473	0.00108	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000471	0.00108	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000469	0.00107	CbGpPWpGaD
Tolazoline—ADRA2B—Hemostasis—IL2—acquired immunodeficiency syndrome	0.000466	0.00107	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000465	0.00106	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000464	0.00106	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000463	0.00106	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000462	0.00106	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000455	0.00104	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000455	0.00104	CbGpPWpGaD
Tolazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000452	0.00104	CbGpPWpGaD
Tolazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000444	0.00102	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000438	0.001	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—ALB—acquired immunodeficiency syndrome	0.000436	0.000998	CbGpPWpGaD
Tolazoline—ADRA2C—Hemostasis—IL2—acquired immunodeficiency syndrome	0.000435	0.000997	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000432	0.00099	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000429	0.000983	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000428	0.000979	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000424	0.000972	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000424	0.000971	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000423	0.000968	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000421	0.000964	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.00042	0.000961	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000416	0.000953	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000413	0.000946	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000399	0.000913	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000399	0.000913	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000396	0.000908	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.00039	0.000894	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.00039	0.000893	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000387	0.000885	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000385	0.000882	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000384	0.000879	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000383	0.000877	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000378	0.000865	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000373	0.000853	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000373	0.000853	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000356	0.000815	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—IL2—acquired immunodeficiency syndrome	0.000354	0.00081	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000353	0.000809	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000351	0.000804	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000347	0.000793	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000332	0.00076	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000332	0.00076	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000326	0.000746	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000326	0.000746	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000322	0.000737	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000304	0.000695	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000303	0.000693	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000303	0.000693	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000299	0.000685	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000295	0.000674	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000284	0.000649	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000279	0.000639	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000275	0.00063	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000273	0.000626	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000269	0.000615	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000267	0.000612	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000267	0.000612	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000255	0.000585	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000253	0.000578	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.00025	0.000572	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000249	0.00057	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000248	0.000567	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000245	0.000561	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000244	0.000559	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000241	0.000551	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.00023	0.000527	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000228	0.000521	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000227	0.000519	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000223	0.000512	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000223	0.000511	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000223	0.00051	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000218	0.0005	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—ALB—acquired immunodeficiency syndrome	0.000218	0.000498	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000207	0.000475	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000203	0.000465	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—ALB—acquired immunodeficiency syndrome	0.000177	0.000405	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000158	0.000362	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.000158	0.000362	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000157	0.00036	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000148	0.000338	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000147	0.000336	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000131	0.000301	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000131	0.0003	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000129	0.000295	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000128	0.000294	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.00012	0.000274	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000119	0.000273	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	9.29e-05	0.000213	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	8.67e-05	0.000199	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.73e-05	0.000177	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.58e-05	0.000174	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.05e-05	0.000161	CbGpPWpGaD
